Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
NCT07695896
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
200
Enrollment
OTHER_GOV
Sponsor class
Conditions
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Interventions
BIOLOGICAL:
Glofitamab
Sponsor
Yanyan Liu